172 related articles for article (PubMed ID: 28855256)
1. From masochistic enzymology to mechanistic physiology and disease.
Vance DE
J Biol Chem; 2017 Oct; 292(42):17169-17177. PubMed ID: 28855256
[TBL] [Abstract][Full Text] [Related]
2. The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion.
Verkade HJ; Havinga R; Shields DJ; Wolters H; Bloks VW; Kuipers F; Vance DE; Agellon LB
J Lipid Res; 2007 Sep; 48(9):2058-64. PubMed ID: 17595447
[TBL] [Abstract][Full Text] [Related]
3. Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.
Jacobs RL; Zhao Y; Koonen DP; Sletten T; Su B; Lingrell S; Cao G; Peake DA; Kuo MS; Proctor SD; Kennedy BP; Dyck JR; Vance DE
J Biol Chem; 2010 Jul; 285(29):22403-13. PubMed ID: 20452975
[TBL] [Abstract][Full Text] [Related]
4. Physiological roles of phosphatidylethanolamine N-methyltransferase.
Vance DE
Biochim Biophys Acta; 2013 Mar; 1831(3):626-32. PubMed ID: 22877991
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase.
Walkey CJ; Donohue LR; Bronson R; Agellon LB; Vance DE
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12880-5. PubMed ID: 9371769
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine homeostasis and liver failure.
Li Z; Agellon LB; Vance DE
J Biol Chem; 2005 Nov; 280(45):37798-802. PubMed ID: 16144842
[TBL] [Abstract][Full Text] [Related]
7. Insights into the requirement of phosphatidylcholine synthesis for liver function in mice.
Noga AA; Vance DE
J Lipid Res; 2003 Oct; 44(10):1998-2005. PubMed ID: 12837848
[TBL] [Abstract][Full Text] [Related]
8. Boehringer Mannheim Award lecture. Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly.
Vance DE
Biochem Cell Biol; 1990 Oct; 68(10):1151-65. PubMed ID: 2268410
[TBL] [Abstract][Full Text] [Related]
9. Lack of phosphatidylethanolamine N-methyltransferase in mice does not promote fatty acid oxidation in skeletal muscle.
Tasseva G; van der Veen JN; Lingrell S; Jacobs RL; Vance DE; Vance JE
Biochim Biophys Acta; 2016 Feb; 1861(2):119-129. PubMed ID: 26603903
[TBL] [Abstract][Full Text] [Related]
10. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid methylation in mammals: from biochemistry to physiological function.
Vance DE
Biochim Biophys Acta; 2014 Jun; 1838(6):1477-87. PubMed ID: 24184426
[TBL] [Abstract][Full Text] [Related]
12. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.
Ling J; Chaba T; Zhu LF; Jacobs RL; Vance DE
Hepatology; 2012 Apr; 55(4):1094-102. PubMed ID: 22095799
[TBL] [Abstract][Full Text] [Related]
13. Choline supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon action.
Wu G; Zhang L; Li T; Zuniga A; Lopaschuk GD; Li L; Jacobs RL; Vance DE
J Biol Chem; 2013 Jan; 288(2):837-47. PubMed ID: 23179947
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
15. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance.
Wan S; van der Veen JN; Bakala N'Goma JC; Nelson RC; Vance DE; Jacobs RL
FASEB J; 2019 Oct; 33(10):10986-10995. PubMed ID: 31284753
[TBL] [Abstract][Full Text] [Related]
16. Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-/- Mice.
Cole LK; Dolinsky VW; Dyck JR; Vance DE
Circ Res; 2011 Mar; 108(6):686-94. PubMed ID: 21273556
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrially-targeted bacterial phosphatidylethanolamine methyltransferase sustained phosphatidylcholine synthesis of a Saccharomyces cerevisiae Δpem1 Δpem2 double mutant without exogenous choline supply.
Kobayashi S; Mizuike A; Horiuchi H; Fukuda R; Ohta A
Biochim Biophys Acta; 2014 Sep; 1841(9):1264-71. PubMed ID: 24832487
[TBL] [Abstract][Full Text] [Related]
18. Cystathionine beta-synthase deficiency alters hepatic phospholipid and choline metabolism: Post-translational repression of phosphatidylethanolamine N-methyltransferase is a consequence rather than a cause of liver injury in homocystinuria.
Jacobs RL; Jiang H; Kennelly JP; Orlicky DJ; Allen RH; Stabler SP; Maclean KN
Mol Genet Metab; 2017 Apr; 120(4):325-336. PubMed ID: 28291718
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of phosphatidylethanolamine N-methyltransferase 2 in CHO-K1 cells does not attenuate the activity of the CDP-choline pathway for phosphatidylcholine biosynthesis.
Lee MW; Bakovic M; Vance DE
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):905-10. PubMed ID: 9003379
[TBL] [Abstract][Full Text] [Related]
20. A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling.
van der Veen JN; Lingrell S; McCloskey N; LeBlond ND; Galleguillos D; Zhao YY; Curtis JM; Sipione S; Fullerton MD; Vance DE; Jacobs RL
FASEB J; 2019 Apr; 33(4):5045-5057. PubMed ID: 30615497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
